No Data
Goldman Sachs Sticks to Its Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Fresenius Continues Its Biopharma Momentum With Launch of Subcutaneous Formulation of Tyenne (Tocilizumab-aazg) in the United States
Tyenneis the first tocilizumab biosimilar available with both an intravenous and subcutaneous formulation approved by the FDA. The subcutaneous formulation of the tocilizumab biosimilar provides inc
Fresenius Medical Care CEO Remains Confident Amid Weight-Loss-Drug Worries
By Helena Smolak The chief executive of Fresenius Medical Care--one of the world's biggest dialysis providers--is confident in the face of investor concerns about the company's vulnerability to weigh
Institutional Owners May Consider Drastic Measures as Fresenius Medical Care AG's (ETR:FME) Recent €719m Drop Adds to Long-term Losses
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading
European equities traded in the US as American depositary receipts were moving sharply higher late Wednesday morning, rising 1.59% to 1,445.87 on the S&P Europe Select ADR Index. From continental Euro
Fresenius Signs Agreements With Wind, Solar Energy Project Developers in US, Germany
Fresenius Medical Care (FMS) said Wednesday it has signed five virtual power purchase agreements in the US and Germany with wind and solar energy project developers. The projects are anticipated to fe